Healthcare utilization and monetary costs associated with agitation in UK care home residents with advanced dementia: a prospective cohort study
- PMID: 31948510
- DOI: 10.1017/S1041610219002059
Healthcare utilization and monetary costs associated with agitation in UK care home residents with advanced dementia: a prospective cohort study
Abstract
Objective: Nearly half of care home residents with advanced dementia have clinically significant agitation. Little is known about costs associated with these symptoms toward the end of life. We calculated monetary costs associated with agitation from UK National Health Service, personal social services, and societal perspectives.
Design: Prospective cohort study.
Setting: Thirteen nursing homes in London and the southeast of England.
Participants: Seventy-nine people with advanced dementia (Functional Assessment Staging Tool grade 6e and above) residing in nursing homes, and thirty-five of their informal carers.
Measurements: Data collected at study entry and monthly for up to 9 months, extrapolated for expression per annum. Agitation was assessed using the Cohen-Mansfield Agitation Inventory (CMAI). Health and social care costs of residing in care homes, and costs of contacts with health and social care services were calculated from national unit costs; for a societal perspective, costs of providing informal care were estimated using the resource utilization in dementia (RUD)-Lite scale.
Results: After adjustment, health and social care costs, and costs of providing informal care varied significantly by level of agitation as death approached, from £23,000 over a 1-year period with no agitation symptoms (CMAI agitation score 0-10) to £45,000 at the most severe level (CMAI agitation score >100). On average, agitation accounted for 30% of health and social care costs. Informal care costs were substantial, constituting 29% of total costs.
Conclusions: With the increasing prevalence of dementia, costs of care will impact on healthcare and social services systems, as well as informal carers. Agitation is a key driver of these costs in people with advanced dementia presenting complex challenges for symptom management, service planners, and providers.
Keywords: economics; healthcare costs; nursing homes; social care costs.
Comment in
-
Unpicking the costs of dementia care in care homes.Int Psychogeriatr. 2020 Mar;32(3):307-309. doi: 10.1017/S104161022000023X. Int Psychogeriatr. 2020. PMID: 32192557 No abstract available.
Similar articles
-
Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study.PLoS One. 2019 Feb 26;14(2):e0211953. doi: 10.1371/journal.pone.0211953. eCollection 2019. PLoS One. 2019. PMID: 30807569 Free PMC article.
-
Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study.J Am Med Dir Assoc. 2018 Jan;19(1):95.e1-95.e10. doi: 10.1016/j.jamda.2017.10.013. J Am Med Dir Assoc. 2018. PMID: 29275939
-
Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial.Lancet Psychiatry. 2019 Apr;6(4):293-304. doi: 10.1016/S2215-0366(19)30045-8. Epub 2019 Mar 11. Lancet Psychiatry. 2019. PMID: 30872010 Clinical Trial.
-
Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs.Southampton (UK): NIHR Journals Library; 2020 Jul. Southampton (UK): NIHR Journals Library; 2020 Jul. PMID: 32721145 Free Books & Documents. Review.
-
The inclusion of informal care in applied economic evaluation: a review.Value Health. 2012 Sep-Oct;15(6):975-81. doi: 10.1016/j.jval.2012.05.009. Value Health. 2012. PMID: 22999150 Review.
Cited by
-
Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from the COSMOS trial.BMC Health Serv Res. 2022 Nov 2;22(1):1306. doi: 10.1186/s12913-022-08675-y. BMC Health Serv Res. 2022. PMID: 36324159 Free PMC article. Clinical Trial.
-
Annual societal cost of Alzheimer's disease in Malaysia: a micro-costing approach.BMC Geriatr. 2025 Mar 6;25(1):154. doi: 10.1186/s12877-025-05717-y. BMC Geriatr. 2025. PMID: 40050715 Free PMC article.
-
The Costs of Dementia in Europe: An Updated Review and Meta-analysis.Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15. Pharmacoeconomics. 2023. PMID: 36376775 Free PMC article.
-
Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD).Health Econ Rev. 2021 Sep 18;11(1):37. doi: 10.1186/s13561-021-00333-z. Health Econ Rev. 2021. PMID: 34536149 Free PMC article. Review.
-
Time Investment for Program Implementation to Manage Neuropsychiatric Symptoms: An Observational Longitudinal Study in In-Home and Residential Care Settings.J Alzheimers Dis Rep. 2020 Oct 24;4(1):441-453. doi: 10.3233/ADR-200235. J Alzheimers Dis Rep. 2020. PMID: 33283165 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical